iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) Shares Acquired by Beaumont Financial Partners LLC

Share on StockTwits

Beaumont Financial Partners LLC boosted its stake in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 2.9% during the fourth quarter, Holdings Channel.com reports. The fund owned 11,298 shares of the financial services provider’s stock after purchasing an additional 323 shares during the quarter. Beaumont Financial Partners LLC’s holdings in iShares Nasdaq Biotechnology ETF were worth $1,362,000 at the end of the most recent reporting period.

Other institutional investors also recently added to or reduced their stakes in the company. McKinley Carter Wealth Services Inc. acquired a new stake in iShares Nasdaq Biotechnology ETF in the 4th quarter valued at $29,000. Financial Advisory Service Inc. acquired a new stake in iShares Nasdaq Biotechnology ETF in the 4th quarter valued at $32,000. Horan Capital Advisors LLC. acquired a new stake in iShares Nasdaq Biotechnology ETF in the 3rd quarter valued at $34,000. Capital Planning Advisors LLC acquired a new stake in iShares Nasdaq Biotechnology ETF in the 3rd quarter valued at $36,000. Finally, Advanced Asset Management Advisors Inc purchased a new position in iShares Nasdaq Biotechnology ETF in the 4th quarter valued at $36,000. 84.58% of the stock is currently owned by hedge funds and other institutional investors.

Shares of IBB stock opened at $121.95 on Friday. The stock’s fifty day moving average is $119.79 and its two-hundred day moving average is $110.99. iShares Nasdaq Biotechnology ETF has a fifty-two week low of $96.03 and a fifty-two week high of $123.74.

Separately, ValuEngine lowered iShares Nasdaq Biotechnology ETF from a “buy” rating to a “hold” rating in a report on Tuesday, October 22nd.

About iShares Nasdaq Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Recommended Story: What sectors are represented in the FTSE 100 index?

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

GAM Holding AG Decreases Holdings in Lear Co.
GAM Holding AG Decreases Holdings in Lear Co.
GAM Holding AG Makes New Investment in FirstEnergy Corp.
GAM Holding AG Makes New Investment in FirstEnergy Corp.
GAM Holding AG Sells 1,916 Shares of Constellation Brands, Inc.
GAM Holding AG Sells 1,916 Shares of Constellation Brands, Inc.
GAM Holding AG Reduces Stock Position in Philip Morris International Inc.
GAM Holding AG Reduces Stock Position in Philip Morris International Inc.
GAM Holding AG Makes New $332,000 Investment in Nordson Co.
GAM Holding AG Makes New $332,000 Investment in Nordson Co.
Cracker Barrel Old Country Store, Inc.  Shares Sold by GAM Holding AG
Cracker Barrel Old Country Store, Inc. Shares Sold by GAM Holding AG


 
© 2006-2020 Zolmax.